Form 4: DENTSPLY SIRONA CFO Gains Shares from RSU Dividends
Insider Transaction Report
Matthew E. Garth, EVP & CFO of DENTSPLY SIRONA Inc., acquired 556.226 shares of common stock through RSU dividend reinvestment.
Summary
- Matthew E. Garth, Executive Vice President and Chief Financial Officer of DENTSPLY SIRONA Inc. (XRAY), acquired 556.226 shares of the company's common stock.
- The transaction occurred on October 10, 2025, with the shares acquired at a price of $0 per share.
- These acquired shares represent dividends on previously awarded restricted stock units (RSUs) and were issued in the form of additional RSUs.
- The newly acquired RSU dividends are subject to the same vesting terms as the underlying awards and will vest simultaneously with them.
- Following this transaction, Mr. Garth's beneficial ownership of DENTSPLY SIRONA common stock totals 44,011.347 shares.
Sentiment
Score: 6
Explanation: The filing reports a routine, non-discretionary acquisition of shares by an executive through RSU dividend reinvestment. This is a neutral event but slightly positive as it increases the executive's stake and aligns interests with shareholders, without indicating any negative operational news.
Positives
- The acquisition of additional shares through RSU dividend reinvestment increases the executive's stake in the company, further aligning management's interests with those of shareholders.
- This routine transaction reflects the ongoing operation of the company's executive compensation plan, which often includes long-term incentives like RSUs.
Negatives
- No direct negatives are identified from this routine insider transaction filing.
Risks
- No specific risks are mentioned or implied by this routine insider transaction filing.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing details a routine insider transaction related to executive compensation. It reflects standard practices for publicly traded companies where executives receive Restricted Stock Units (RSUs) and dividend equivalents, rather than providing insights into broader industry trends or competitive dynamics within the dental products and technologies sector.
Comparison to Industry Standards
- This transaction is a standard practice for executive compensation involving Restricted Stock Units (RSUs) and dividend reinvestment. Many companies, including peers in the medical device and dental supply industry, utilize RSUs as a component of long-term incentive plans to align executive interests with shareholder value.
- For example, companies like Henry Schein, Inc. (HSIC) or Align Technology, Inc. (ALGN) also commonly grant RSUs to their executives, with similar provisions for dividend equivalents.
- The acquisition of shares at a $0 price for RSU dividends is a typical non-cash transaction and is consistent with compensation structures across the industry.
Stakeholder Impact
- Shareholders: Minor positive impact as it increases executive ownership, aligning management's interests with shareholder value.
- Employees, Customers, Suppliers, Creditors: No direct or significant impact mentioned or implied by this routine compensation-related filing.
Key Dates
| Date | Description |
|---|---|
| 10/10/2025 | Date of transaction where Matthew E. Garth acquired shares representing RSU dividends. |
| 10/15/2025 | Date the Form 4 was signed by the attorney-in-fact for Matthew E. Garth. |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary acquisition of shares by a key executive through RSU dividend reinvestment. It does not provide new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment thesis. While it slightly increases executive alignment, it's a standard compensation event and not a signal for significant price movement. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific transaction.
Keywords
DENTSPLY SIRONA, XRAY, Matthew Garth, insider transaction, Form 4, RSU, restricted stock units, dividend reinvestment, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.